Cell ReportsNeurosciencePeer-reviewed journal article
Differential neuronal vulnerability to C9orf72 repeat expansion driven by Xbp1 transcription signature
Dunxin SheniD, Alec J. VincentiD, Evan UdineiD, Yazead BuhidmaiD, Sharifah AnoariD, Elli Tsintzas, Marie Emilie MaelandiD, Dongwei XuiD, Mireia CarcoléiD, David Osumi-SutherlandiD, Benjamin Aleyakpo, Alexander J. HulliD, Guillermo Martínez-CorralesiD, Nathaniel S. WoodlingiD, Rosa RademakersiD, Adrian M. IsaacsiD, Carlo Sala FrigerioiD, Marka van BlitterswijkiD, Tammaryn LashleyiD, Teresa NiccoliiD
Abstract
A G4C2 repeat expansion in the gene C9orf72 (C9) is the most common genetic cause of sporadic and familial frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). What determines why cell death is triggered only in specific neuronal populations, while others remain protected or are less susceptible to disease is still an open question. In particular, whether it is the transcriptional response to the accumulation of toxic insults or the initial cellular state that determines their vulnerability is still unknown. We have carried out a large-scale profiling of single cell transcriptional signatures throughout disease development in a Drosophila model of C9 repeat toxicity. This enabled us to monitor transcriptional shifts and track changes in cell populations during disease progression. We have identified neuronal populations which are depleted in response to C9 repeat expression, and therefore vulnerable to toxicity. On the other hand, other neuron types are resistant to toxicity, and maintain their cell number during disease progression. Our findings suggest that a major determinant of vulnerability is the transcriptional state of the cell before it is exposed to C9 repeat expression. We have identified a conserved transcriptional profile that is associated with resistance to C9 repeat toxicity. Neurons resistant to disease display a higher expression of genes involved in protein homeostasis, with Xbp1 identified as a crucial transcription factor determining neuronal vulnerability.
- organism: Drosophila
- assay: scRNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 7
- FWCI
- 4.23
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Divergent impacts of C9orf72 repeat expansion on neurons and glia in ALS and FTD
Junhao Li, Manoj K. Jaiswal, … Stella M. Dracheva·Nature CommunicationsPeer-reviewed·Sep 15, 2023
- Glial cell-intrinsic and non-cell autonomous toxicity in a Drosophila C9orf72 neurodegeneration model
Isabel Hubbard, Josh Dubnau·bioRxiv·Oct 7, 2025
- Cell cycle dysregulation contributes to neurodegeneration in humanneurons from ALS/FTD-related C9orf72 repeat expansion carriers.
SK Imran Ali, Ling Lian, … Rodrigo Lopez-Gonzalez·bioRxiv·Jun 4, 2025
- C9orf72-associated G4C2 hexanucleotide repeat expression in Drosophila mushroom bodies causes age dependent TDP-43 pathology and dementia relevant phenotypes mediated in part by the glypican Dlp/GPC6
Brijesh Singh Chauhan, Megan Alexandria Brennan, … Daniela C. Zarnescu·Acta Neuropathologica CommunicationsPeer-reviewed·Oct 26, 2026
- Aberrant splicing exonizes C9ORF72 repeat expansion in ALS/FTD
Suzhou Yang, Denethi Wijegunawardana, … Junjie U. Guo·Nature NeurosciencePeer-reviewed·Aug 11, 2025
- Neuronal Activity-Dependent Gene Dysregulation in C9orf72 i3 Neuronal Models of ALS/FTD Pathogenesis
Layla Ghaffari, Emily M. Welebob, … Aaron R. Haeusler·American Journal of Physiology-Cell PhysiologyPeer-reviewed·Aug 28, 2025